IMI plc Stock Slides Despite £500m Buyback as May 12 Update Looms

May 2, 2026
IMI plc Stock Slides Despite £500m Buyback as May 12 Update Looms

LONDON, May 2, 2026, 19:07 BST

IMI plc slipped 2.01% to end Friday at 2,736 pence, trailing the FTSE 100’s more modest decline as another buyback announcement from the UK engineering group failed to spark interest. Shares now sit 6.88% off the 52-week high.

Timing’s key here. IMI’s set to deliver its first-quarter trading update and convene its annual general meeting on May 12—investors will be watching for numbers on orders, margins, and signs that cash returns are actually backed by underlying momentum.

On May 1, IMI reported it snapped up 104,734 ordinary shares on April 30, executing the purchase through J.P. Morgan Securities for cancellation. The average price? 2,788.3815 pence per share—roughly £2.9 million altogether. That figure reflects the volume-weighted average, so each trade’s size factored into the price. Once the shares settle and are cancelled, IMI’s total ordinary shares will drop to 254,093,221, with 241,444,385 voting rights remaining.

The trade itself is a drop in the bucket. What gives it weight is its place in IMI’s £500 million buyback, rolled out in March. That was when the company posted 2025 revenue of £2.304 billion, adjusted operating profit at £460 million, and a 20.0% margin on that metric. Organic revenue—factoring out M&A, disposals and FX—was up 5%. Chief Executive Roy Twite called the approach “creating significant value for shareholders.” Investegate

Back in March, IMI put out guidance for 2026, telling investors to expect adjusted basic earnings per share somewhere between 136p and 142p. The company is also projecting its sixth consecutive year of organic revenue growing at a mid-single-digit rate. EPS, short for earnings per share, reflects profit allocated to each share—buybacks or share cancellations can give that number a lift if overall profits stay steady.

This isn’t a one-trick play. Reuters calls IMI a specialist engineering company focused on designing, building and servicing products used in fluid and motion control. Automation and Life Technology make up its two primary segments. Stripped down, that means equipment handling flow, pressure and movement for industrial and other uses.

That sharpens the comparison with its peer. Rotork, which brands itself as a provider of flow-control solutions for liquids and gases, gained 2.33% to 316p on May 1, Investing.com data show. The move highlights that IMI’s Friday slip wasn’t just a sector-wide drop in the UK flow-control and automation segment.

Even so, Friday saw light action. Reuters noted volumes on London exchanges lagged their 20-day moving average, with most European markets shut and the UK starting a bank holiday. That means a single day’s swing might not say much.

The real worry comes from demand, not market action. Should industrial automation orders lose momentum or Life Technology stumble on improvement, the buyback might only boost per-share figures while leaving core earnings untouched. That scenario would make the May 12 update a much tougher hurdle than a simple progress report.

Right now, IMI offers investors a clear exchange—cash returns, fewer shares in play, and the stock dropping ahead of the next update. The key question for the market: is the business itself keeping pace?

Stock Market Today

  • Australia Nano Water Test Kit Market to 2035: Imports, Premiumisation, and Subscription Trends
    May 13, 2026, 2:59 PM EDT. The Australian Nano Water Test Kit market relies heavily on imports, with 85-95% of kits sourced mainly from China, the US, and Europe. Entry-level test strips dominate volume but premium digital and laboratory kits are growing at two to three times the rate, driven by stricter regulations and consumer demand for accuracy. Recurring demand links to infrastructure aging and climate events such as bushfires. Subscription models are reshaping the market by bypassing retailers, while private label expansions compress prices at entry levels. Challenges include maintaining kit accuracy under Australia's harsh conditions and competing with free municipal water quality reports, limiting potential market growth.